Complete Filing Data
Meihua International Medical Technologies Co., Ltd. reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents of $17.29 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Meihua International Medical Technologies Co., Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Net Income * | $10.8M | $11.6M | $6.2M | $20.9M | $19.0M | $15.4M |
| Revenue * | $96.9M | $97.1M | $103.3M | $104.0M | $816.6K | $826.5K |
| Income Tax Expense Benefit | $2.8M | $3.5M | $4.7M | $5.3M | $4.7M | $3.8M |
| Research And Development Expense | $3.5M | $2.8M | $3.0M | $2.7M | $2.5M | $3.2M |
| Operating Income Loss | $14.3M | $14.7M | $10.8M | $26.3M | $23.5M | $19.4M |
| Operating Expenses | $19.0M | $18.5M | $27.3M | $13.5M | $13.7M | $12.8M |
| Nonoperating Income Expense | -$685.8K | $373.8K | $89.3K | -$32.9K | -$267.4K | $137.7K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $13.6M | $15.0M | $10.9M | $26.2M | $23.7M | $19.2M |
| Gross Profit | $33.3M | $33.2M | $38.1M | $39.8M | $37.2M | $32.2M |
| General And Administrative Expense | $7.8M | $6.5M | $12.5M | $4.4M | $4.6M | $4.2M |
| Cost Of Revenue | $63.6M | $63.9M | $65.2M | $64.2M | $51.9M | $47.4M |
| Comprehensive Income Net Of Tax | $6.6M | $8.2M | -$2.9M | $23.0M | $23.8M | $14.9M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$4.3M | -$3.4M | -$9.2M | $2.1M | $4.8M | -$579.9K |
| Income Taxes Paid | $3.7M | $3.6M | $5.7M | $5.0M | $4.4M | $3.9M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$4.3M | -$3.4M | -$9.2M | $2.1M | $4.8M | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $6.6M | $8.2M | -$3.0M | $23.0M | $23.8M | |
| Revenue From Third Party Sales | $103.3M | $103.5M | $88.2M | $78.8M | ||
| Interest Income Expense Net | -$1.5M | -$250.8K | -$194.7K | -$180.7K | $137.2K | $97.8K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $159.0M | $146.3M | $138.1M | $107.8M | $84.7M | $59.7M | $44.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $17.3M | $16.9M | $26.7M | $8.1M | $7.2M | $16.0M | $14.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $362.1K | -$9.8M | $18.6M | $961.9K | -$8.8M | $1.2M | |
| Repayments Of Other Short Term Debt | $5.9M | $6.2M | $4.7M | $3.9M | $2.0M | ||
| Long Term Investments | $22.4M | $6.1M | $6.7M | $941.5K | $919.5K | ||
| Taxes Payable Current | $1.2M | $1.1M | $1.1M | $2.1M | $1.7M | ||
| Retained Earnings Accumulated Deficit | $105.2M | $94.6M | $83.3M | $77.6M | $56.6M | ||
| Property Plant And Equipment Net | $7.9M | $8.8M | $8.8M | $7.5M | $7.1M | ||
| Prepaid Expense And Other Assets Current | $9.7M | $14.2M | $16.4M | $1.4M | $496.6K | ||
| Liabilities Current | $27.3M | $25.1M | $24.2M | $29.1M | $21.3M | ||
| Liabilities And Stockholders Equity | $186.2M | $171.9M | $163.6M | $136.9M | $106.0M | ||
| Liabilities | $27.3M | $25.1M | $24.9M | $29.1M | $21.3M | ||
| Inventory Net | $1.4M | $1.6M | $1.1M | $1.3M | $1.3M | ||
| Intangible Assets Net Excluding Goodwill | $443.0K | $3.9M | $497.6K | $562.0K | $575.5K | ||
| Gain Loss On Disposition Of Assets | -$111.00 | -$25.0K | -$15.3K | -$2.9K | $9.5K | ||
| Common Stock Value | $16.0K | $12.0K | $12.0K | $10.0K | $10.0K | ||
| Assets Current | $143.4M | $132.2M | $135.3M | $97.3M | $67.6M | ||
| Assets | $186.2M | $171.9M | $163.6M | $136.9M | $106.0M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$11.5M | -$7.3M | -$3.9M | $5.3M | $3.2M | ||
| Accounts Receivable Net Current | $78.7M | $78.6M | $68.9M | $67.1M | $45.7M | ||
| Accounts Payable Current | $15.5M | $15.8M | $16.1M | $21.0M | $15.6M | ||
| Accounts Payable And Other Accrued Liabilities Current | $1.3M | $842.2K | $856.7K | $847.1K | $708.6K | ||
| Notes Receivable Net | $20.4M | $22.1M | $19.4M | $12.5M | |||
| Cash | $16.9M | $26.7M | $8.1M | $7.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Payments To Acquire Property Plant And Equipment | $133.6K | $1.2M | $2.7M | $850.2K | $3.8M | $266.7K |
| Net Cash Provided By Used In Operating Activities | $14.6M | $2.3M | -$9.2M | -$54.7K | $5.3M | $9.3M |
| Net Cash Provided By Used In Investing Activities | -$20.4M | -$12.5M | -$8.6M | -$833.8K | -$16.1M | -$8.9M |
| Net Cash Provided By Used In Financing Activities | $6.2M | $706.1K | $37.2M | $1.9M | $1.7M | $923.8K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.3M | -$1.8M | $4.9M | $861.8K | $367.2K | -$234.4K |
| Increase Decrease In Inventories | -$165.8K | $528.6K | -$35.0K | -$105.1K | $219.8K | -$802.6K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $596.2K | $9.9K | $75.9K | $120.1K | $102.7K | -$180.8K |
| Increase Decrease In Accrued Income Taxes Payable | $188.4K | -$16.9K | -$812.4K | $288.7K | $598.1K | -$447.5K |
| Increase Decrease In Accounts Receivable | $4.3M | $13.6M | $7.1M | $20.1M | $13.6M | $4.7M |
| Increase Decrease In Accounts Payable | $932.5K | $185.9K | -$3.4M | $4.9M | $5.3M | -$4.2M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$67.5K | -$333.0K | -$874.7K | -$9.8K | $218.1K | -$103.3K |
| Proceeds From Sale Of Property Plant And Equipment | $348.3K | $23.1K | $16.4K | $25.2K | $50.6K | |
| Proceeds From Short Term Debt | $10.6M | $6.6M | $7.6M | $6.5M | $4.4M | $2.6M |
| Increase Decrease In Due From Related Parties | -$396.6K | $222.5K | $22.5K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 27.4M | 23.9M | 23.4M | 20.0M | 20.0M | 18.6M |
| Earnings Per Share Basic | $0.40 | $0.49 | $0.27 | $1.05 | $0.95 | $0.83 |
| Weighted Average Number Of Diluted Shares Outstanding | 27.4M | 23.9M | 23.4M | 20.0M | 20.0M | |
| Earnings Per Share Diluted | $0.49 | $0.27 | $1.05 | $0.95 | ||
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 31.9M | 23.9M | 20.0M | 20.0M | 20.0M | |
| Common Stock Shares Issued | 31.9M | 23.9M | 20.0M | 20.0M | 20.0M | |
| Common Stock Shares Authorized | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Selling Expense | $6.6M | $7.3M | $7.1M | $6.5M | $6.6M | $5.4M |
| Interest Paid Net | $247.6K | $250.8K | $194.7K | $180.7K | $137.2K | $97.8K |
| Foreign Currency Transaction Gain Loss Before Tax | $380.3K | -$153.4K | $273.4K | $174.4K | -$393.5K | $89.5K |
| Short Term Borrowings | $58.0M | $52.0M | $6.1M | $5.2M | $3.2M | |
| Other Operating Income Expense Net | $53.2K | $50.4K | $25.6K | -$735.00 | ||
| Additional Paid In Capital | $49.2M | $43.0M | $43.0M | $9.7M | $9.7M | |
| Depreciation | $543.7K | $408.2K | $541.3K | $595.5K | ||
| Statutory Accounting Practices Statutory Capital And Surplus Required | $16.0M | $15.7M | $15.2M | $15.2M | ||
| Investment Income Investment Expense | $63.7K | $23.9K | $36.6K | $48.8K | ||
| Stock Redeemed Or Called During Period Value | $33.3M | -$344.7K | $344.7K | |||
| Investment Income Interest | $1.0M | $873.4K | $63.7K | $23.9K |
Most recent annual filing with the SEC: April 25, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.